Sign Up to like & get
recommendations!
0
Published in 2019 at "Drugs"
DOI: 10.1007/s40265-019-01158-1
Abstract: For more than 20 years, the combination of a platinum agent and a taxane has served as the primary chemotherapy strategy for epithelial ovarian cancer. Alternative approaches employing these drugs (intraperitoneal drug delivery, neoadjuvant therapy) have…
read more here.
Keywords:
cancer current;
current status;
pharmaceutical management;
ovarian cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert opinion on pharmacotherapy"
DOI: 10.1080/14656566.2022.2064218
Abstract: INTRODUCTION Sexual dysfunction (SD) and depression have a bidirectional relationship. The rising prescription of antidepressants, especially those with a serotonergic effect, is associated with increased SD. Sexual dysfunction reduces compliance and increases risk of recurrence…
read more here.
Keywords:
sexual dysfunction;
dysfunction;
risk;
pharmaceutical management ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.00559
Abstract: The current clinical guidelines on post-traumatic stress disorder (PTSD) recommend selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) of drugs. However, there is uncertainty about the efficacy of other drugs and…
read more here.
Keywords:
medicine;
efficacy;
management;
pharmaceutical management ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.805354
Abstract: Objective: This study assessed the efficacy, acceptability, and safety of pharmaceutical management for combat-related post-traumatic stress disorder (PTSD) to provide a clinical decision-making basis for clinicians. Method: A comprehensive search was conducted using Ovid MEDLINE,…
read more here.
Keywords:
pharmaceutical management;
combat;
smd;
related ptsd ... See more keywords